Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

At the CXO-Entrepreneurs Alumni Meet 2024, hosted by MIT World Peace University (MIT-WPU), thought leaders and ...

Bengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight management.

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight ...

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...

Biocon Limited, alongside its European partner Zentiva, has successfully obtained approval for their generic version of ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...